Hawkins will take on the challenge of growing the company's existing businesses that manufacture devices to treat diabetes, heart disease, and spinal and neurological conditions. He'll also have to deal with the controversial issues surrounding defibrillators, as industry recalls have resulted in a "sharp downturn" in sales of the products.
0 comments
Hide comments
